Literature DB >> 6457839

Spinal cord dysfunction in Paget's disease of bone. Has medical treatment a vascular basis?

D L Douglas, T Duckworth, J A Kanis, A A Jefferson, T J Martin, R G Russell.   

Abstract

The medical treatment of eight patients with paraparesis associated with Paget's disease of the vertebrae is described. Treatment, for 3 to 87 months, with calcitonin or with diphosphonates produced marked clinical improvement in seven of these patients. From this series and a review of 19 additional case reports it is concluded that favourable clinical response is seen in about 90 per cent of patients, and that this may occur very rapidly. Results are as good or better than those obtained by surgical decompression. It seems possible that paraparesis in some cases may be due to diversion of blood supply from the spinal cord to the highly vascular Pagetic bone giving rise to a vascular "steal" syndrome. It is suggested that medical treatment should be used more widely to avoid or delay the need for operation and reduce the risks of recurrence. These patients, however treated, require lifelong follow-up because relapses are common.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6457839

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  13 in total

1.  Paget's disease of bone.

Authors:  R Smith
Journal:  BMJ       Date:  1992-12-05

2.  Randomised placebo-controlled trial on the effectiveness of nasal salmon calcitonin in the treatment of lumbar spinal stenosis.

Authors:  Suhayl I Tafazal; Leslie Ng; Philip Sell
Journal:  Eur Spine J       Date:  2006-07-25       Impact factor: 3.134

3.  Treating Paget's disease.

Authors:  J A Kanis; R E Gray; E V McCloskey
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-20

4.  Calcitonin for pseudoclaudication in lumbar spinal stenosis.

Authors:  J Streifler; R Hering; N Gadoth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-04       Impact factor: 10.154

5.  Carcinoma of the prostate: remission of paraparesis with inhibitors of bone resorption.

Authors:  R C Percival; M E Watson; J L Williams; J A Kanis
Journal:  Postgrad Med J       Date:  1985-06       Impact factor: 2.401

Review 6.  Management of Paget's disease of bone.

Authors:  I R Reid
Journal:  Osteoporos Int       Date:  2019-12-17       Impact factor: 4.507

Review 7.  Paget's disease of bone: diagnosis and management.

Authors:  D Hosking; P J Meunier; J D Ringe; J Y Reginster; C Gennari
Journal:  BMJ       Date:  1996-02-24

Review 8.  Principles of management of osteometabolic disorders affecting the aging spine.

Authors:  Alexander G Hadjipavlou; Paul G Katonis; Michael N Tzermiadianos; George M Tsoukas; George Sapkas
Journal:  Eur Spine J       Date:  2003-09-23       Impact factor: 3.134

Review 9.  Lumbar spinal stenosis in the elderly: an overview.

Authors:  Marek Szpalski; Robert Gunzburg
Journal:  Eur Spine J       Date:  2003-09-09       Impact factor: 3.134

Review 10.  Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.

Authors:  G L Plosker; K L Goa
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.